vvEPA
               United States
               Environmental Protection
               Agency
            Office of
            Solid Waste and
            Emergency Response
DIRECTIVE NUMBER:  948i.13(84)

TITLE: Establishing Alternate Concentration Limits (ACLs)
    ' . for RCRA Permits          .......
                APPROVAL DATE: n-19-84

                EFFECTIVE DATE: n-19-84

                ORIGINATING OFFICE: office of Solid "waste

                0 FINAL

                D DRAFT
                           -C :I   ~ PeninS OMB "approval '••'
                           ,[ ]  B-; Pending 'AA-OSWER approval-^
                           '[ ].  ..C-.;For-ireyiew_.&/or- comment :-^--^
                           [ ;]•  ;-D-
-------
 PARTS  264  AND  265   SUBPART  F  - GROUND-WATER  PROTECTION        DOC:  9481.13(84)


 Key  Words:     Alternate  Concentration  Limit  (ACL), Risk, RCRA Permits

 Regulations:   40 CFR  264.94(b)   .

 Subject:       Establishing  Alternate Concentration Limits (ACLs) for RCRA
               Permits

 Addressee:     Morris  Kay, Regional Administrator, Region VII

 Originator:    Lee M.  Thomas,  Assistant Administrator

 Source Doc:    #9481.13(84)

 Date:          11-19-84

 Summary:

     An ACL demonstration must justify all claims regarding the potential effects
 of ground—water contaminants  on human health and the environment.  This process
 requires risk  analysis and  risk management.  In terras of human considerations,-
 the  regulations require  assessments of toxicity, exposure pathways, and exposed
 populations.

     To obtain an ACL, a permit applicant must demonstrate:  a) that there will
 be no exposure, or b) that  the exposure will be at levels which do not pose a
 substantial threat to human health and the environment.  In the latter case,
 the applicant must distinguish between ground-water contaminants having threshold
 (toxic) and nonthreshold (carcinogenic) effects.  Acceptable exposure levels
 for threshold contaminants  can be derived from acceptable daily intakes (ADIs).
 The acceptable concentration  of non-threshold compounds or carcinogens is
 determined through the risk management process.  In general, the Agency allows
 concentrations of carcinogens where the individual risk values are within the
 10~^ to 10~° range.   Acceptable risk levels to any exposed individual within
 the 10"^  to 10~° range.  Acceptable risk levels to any exposed individual within
 the 10"^  to 10~° range must be established on a site-by-site basi-s, taking
 into account various factors.

     In general, permit writers should encourage owners and operators to consider
 a level of 10~° to be used  as a point of departure when proposing a risk level
within the 10~4 to ICT8 range for their particular facility.

     ACLs are established at  the waste management boundary point of compliance.
The risk  levels are  determined at the designated point of use.  The designated
point of  use where potential  exposure may occur is at any point downgradient  of
the property boundary, unless there are controls beyond the present boundary
 that will prevent use of the  affected resource.

-------
MEMORANDUM
                      WASHINGTON. D.C. 20460
                                9 :?3
                                                                 9481.13 (84!
                                              SOl-iQ WASTE ANO EMERGENCY B6SPQNSE
SUBJECT:  International Pa/pkr ACI—JDemonstrat ion
FROM:
TO:
Lee M.  Thomas
Assistant Administrator

Morris  Kay
Regional  Administrator
Region  VII
     This memo is in response to a request from David Wagoner
to John Skinner for guidance concerning the setting of accepta-le
risk levels for carcinogenic constituents in establishing
alternate concentration limits.

     Alternate concentration limits (ACLs) can be established
for hazardous constituents identified in the ground water  if
the constituent will not pose a substantial -resent or potential
hazard to h-man he-alth or the environment as Long as the limit
is not exceeded at the edge of the waste mar. = ~e~.ent area.
This process involves risk analysis and risk management.   The
ACL demonstration must justify all claims retarding the potential
effects of ground water contaminants on human health and the
environment.  In terms of human considerations, the regulations
require assessments of toxicity, exposure pat-ways, and exposed
populations.  The relevant factors listed in J254.94(b) include:

     *_  physical and chemical characteristics of the waste

     0  hydrogeolcgica1 characteristics cf the sice

     0  ground water flow rate and direction

     9  proximity and withdrawal rates of grcjnd water  users

     0  proximity of surface waters to the site

     0  current and future uses of ground water  in  the  area

     0  current and future uses of surface waters  in  the  area and
        any applicable standards

-------
     0  potential health risks of each waste constituent

     0  persistence and permanence of potential adverse effects.

     There are two approaches open to an owner or operator of a «*
facility to make the necessary ACL demonstration:

     (1) that there will be no exposure, or

     (2) that the exposure will be at levels which do not
         pose a substantial threat to human health and the
         environment.

In the second approach, the permit applicant must distinguish
between ground water contaminants having threshold (toxic) and
non-threshold (carcinogenic)  effects.  Acceptable exposure levels
for threshold contaminants can be derived from acceptable daily
intakes (ADIs).   Draft guidance on the usa of ADIs has been
published by the Agency (Guidance and Methods for the use of
Acceptable Daily Intakes in Health Risk Assessment, U.S. EPA, .
1934).   The acceptable concentration of non-threshold compounds,
or carcinogens,  is determined through the risk management process.
Several contaminants in Appendix VIII have unit cancer risk
(UCR)  values associated with them.  The UCR values are used to
estimate water concentrations that correspond to lifetime statistical
cancer risk values.  The lifetime statistical cancer risk value
must be chosen during  the risk management process.  In general,
the Age_ncy has made decisions to allow concentrations of carcinogens
where  the individual risk values have been within the range of
1CT4 to 10"a.

     For setting ACLs  for RCRA permits you should consider, the
following factors in determining an acceptable risk level to any
exposed individual within the 10~4 to 10~3 range:

     (1).  .other environmental health factors iorne by
          the affected population, i.e., are they already
          exposed to known air, water, or other pollutants
          such that they have a high risk loa-J.;

     (2)   level  of uncertainty in the data base ar.d models
          used in the  risk analysis;

     (3)   expected effectiveness and reliaoility of man-made
          systems affecting exposure (e.g., slurry walls, pumping
          wells, and the likelihood that off-site wells will  alter
          ground-water flow patterns);

     (4)   current and  expected future use of the affected
          resource;

-------
      (5)   impacts upon the environment (i.e., receiving ecosystem)
           ac any surface water to which the plume will discharge.

      It  is-generally useful to also determine the total population
that  is  currently exposed or lively to be exposed in the future,
and the  cost or cost effectiveness of the corrective action or •*
engineered solution.  These considerations may be useful for public
hearings and for weighing the importance of the five factors.
Many  of  the factors that are critical to setting ACLs are site
specific.  Therefore, acceptable individual risk levels for
non-threshold compounds must be established on a site-by-site
basis.   When applying these risk management factors to an ACL
demonstration, both the current and potential impacts must be
considered.  It is also necessary to consider the above factors
in the context of the §254.94(b)  criteria.

      The site conditions at the International Paper (I?) facility
in Joplin, Missouri, are similar to the Reilly Tar Superfund Site
in St. Louis Park, Minnesota.  Both facilities were wood preserving
plants that operated for -lore than 50 years.  The facilities
used  a creosote preserving process.  The chemical compounds
associated with this process are polynuclear aromatic hydrocarbons
(PAH) and  phenolics.  Many of the PAHs are potent carcinogens.
At both  sites, PAHs have entered shallow aquifers.  The subsurface
geology  at both sites is such that movement of contaminants can
occur without significant attenuation.  The drinking water aquifer
at the Reilly Tar site is contaminated and the drinking water
aquifer  at the I? facility is threatened.

      On  June 6, 1984, I signed the Record of-Decision for the
Reilly Tar Pits Superfund Site.   In this decision, I selected a
remedy that allowed a ris'< level of 10"^  (one chance in a million)
in determining acceptable concentrations of carcinogenic compounds
in water used as drinking water.   In this case the concentration
level, in  the absence of any applicable standards, was selected
on the judgement that-it was effective in protecting human health
and could  reasonably be implemented.  In the I? case, consideration
of the five factors outlined above may support a different risk
level (higher or lower) as providing an acceptable level of
protection to human health.  However, in the I? case, serious
consideration should be given-to the 1Q~^ ris<; level because
of the similarity between the two sites and the need for consistency
under similar circumstances.  As a general matter, I recommend
that  permit writers encourage owners and operators to consider  a
level of 10"°, the middle of the range, to be used as the
point of departure when proposing a risk level within the  10~4
to 10~3  range for their particular facility.

-------
     ACLs are established ac  the  waste  managemenc  boundary
of compliance).  The risk levels  are  determined  at the d£.= •-.7-2.^.ed
point of use.  The allowable  concentration of  carcinogen:.;  compound
at the designated point of use would  not  be expected to '2-5  -exceeded
as long as the ACL at  the compliance  point is  not  exceedii,   T'la
designated point of use where potential exposure may occ-ir  is at
any point downgradient of the property  boundary, unless t'iwrs
are controls beyond the present boundary  that  will prever.t  U£S-*i
of the affected resource (e.g., State or  local controls, or
restrictions).  Since  no such controls  are in  place at I"**
potential exposure point is at or within  IP's  property iou-ii
In order to designate  the property boundary as the point -•£
exposure, I? must ensure that there are permanent  prohii L~z~
on the use of on-site ground  water as a source o£  drinka-t;;
or for any other use that would not be  protective  of huiran-
and the environment.  These restrictions  must  apply to 1?
it retains ownership for the  site,  as well as  to any succ^-
in interest.

cc:  Jack McGraw
     Marjorie Russell
     Merrill S. Hohman
     Conrad Simon
     Stephen R. Wassarsug
     David Wagoner
     Tom Devine
     Bill Constantelos
     Aliyn M. Davis
     Robert L. Duprey
     Harry Seraydarian
     Charles E. Findlev
     OSW Senior Staff
     Lisa Friedman
     Mark Greenwood

-------
         UNITED STATES  ENVIRONMENTAL PROTECTION AGENCY

                                  REGION  VII
                           324 EAST ELEVENTH STREET
                         KANSAS CITY. MISSOURI - 641C6
MEMORANDUM

SUBJECT:  Final Response oa ACLs for International Paper Company,
          Joplin, Missouri
                                  '  /'
FROM:     David A. Wagoner         /'/;,  ,  /
          •Director, Air and Waste'^wn-a^omeri't-Division, Region VII

TO:       John H. Skinner    (WH-5523)
          Director, Office of Solid Waste

     You and I have previously discussed the alternate concentration limits
(ACL) proposed by International  Paper Company (IP) for their Joplin, Missouri
facility.  I? has proposed to use amoient health criteria (human toxicity
values or 10~5 cancer risk level's) as their alternate concentration limits
at the point of compliance.  Attached is the portion of our response letter
which covers tne ACL issue.

     We plan to approve the proposed ACL for oenzo(a)pyrene based on the
10~5 criteria.  We also plan to reduce the proposed ACL for pentachlorophenol
from tne toxicity criteria of 1.01 mc/1  to the estimated organoleptic level
of 30 ug/1,  since values above 30 ug/i  would rende- :ne groundwater unsuitable
for driruing.

     If you  disagree with eitne- of these approacr-js,  please let us know by
COB F'-iaay,  Octooer 5,  1934.  Ue plan to transmit o--- comments by that date
unless we hear from you.  Please call 3ob Stewart o'- Lynn Harrington at
753-6531, or myself at  753-6529.

Attachment

-------
Alternate Concentration Limits

33.  We agree that you have followed generally appropriate methodologies
in preparing the Acceptable exposure Levels in the May 1984 Supplement.
We also agree with the ACL value proposed for benzo(a)pyrene of 0.023 ug/1.
However, we feel that the organoleptic level of 30 ug/1 snould be the ACL
for pentachlorophenol, since concentrations in the groundwater at that
level could prohibit the use of the supply  for drinking water.

     You snould now proceed to prepare proposed ACLs for the remainder of
the Appendix VIII compounds identified in the groundwater or sludge.  We
will expect to receive these proposals by Oecemoer 14, 1984.

34.  There appear to be typos on pages 32 and 50 of the Supplement for
the no effect level for benzo(a}pyrene.  Based on othe.'' pages and tables,
the correct level would be 0.028 ug/1, not mg/1.  In addition, 3aP does
not have a calculated no effect thresnold.  The published EPA criterion  in
ambient water of .028 ug/1 is associated with an excess, lifetime cancer
risx of 10-3.

35.  You should also consider dermal contact and aquatic life effects due
to the springs, seeps and creeks soutnwest  of the site.  Concentrations
snould be specified for tne discussion on page 48 concerning dermal effects,

36.  There appears to be an error in Table  3, page 13  of Appendix A.  Fo1"
tne ratio of tumors to rats witn tumors, control males snould be 1.0.

37.  The Table 2 referenced on page 17 of Appendix A :$ missing.

38.  The first 2 sentences of section 5.1 are correct.  We know of no
published methodology, however, that could  be used to  estimate a criterion
for 3aP based on snort term subcutaneous aosing.  We suggest that this
calculation be deleted.

39.  You should reference the last statement on page 3-i.

-------